Lyell Immunopharma Inc — Stato Patrimoniale (NASDAQ:LYEL) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 1.13 B937.56 M750.03 M490.86 M340.05 M Totale passività 197.62 M104.31 M95.08 M108.03 M91.85 M Patrimonio netto totale 929.79 M833.25 M654.95 M382.82 M248.2 M Totale passività e patrimonio netto 1.13 B937.56 M750.03 M490.86 M340.05 M Debito totale ————— Indebitamento netto —————

Notizie

Lyell Immunopharma Stock (LYEL) Slides Despite Praise from a Top Wall Street Analyst - TipRanks.com

Morning News Wrap-Up 4/10/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet (NASDAQ:LYEL)

H.C. Wainwright conferma il rating buy su Lyell Immunopharma

Citizens conferma il rating su Lyell Immunopharma per i progressi degli studi

Citizens reiterates Lyell Immunopharma stock rating on trial progress

Avago, Lumentum among market cap stock movers on Monday

Lyell Immunopharma chiude tranche azionaria da 50 milioni di dollari e nomina nuovo CFO

Lyell Immunopharma closes $50M equity tranche, names new CFO

Citizens avvia copertura su Lyell Immunopharma con rating outperform, target $34

Citizens initiates Lyell Immunopharma stock at outperform, $34 target

Lyell Immunopharma, Inc. (LYEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript